Apnimed, Inc. (APMD) vs Mesa Laboratories, Inc. (MLAB)

A side-by-side comparison of Apnimed, Inc. and Mesa Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

APMD

Apnimed, Inc.

$790M

$19.85HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

MLAB

Mesa Laboratories, Inc.

$770M

$137.59HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT

Total return — APMD vs MLAB

growth of $100 · dividends reinvested · last 1y

APMD +35.9% (+35.9%/yr)MLAB +45.7% (+45.7%/yr)MLAB compounded faster over this window

APMD MLAB

Metrics side by side

Total return (annualized)

Metric	APMD	MLAB
Total return (1Y)	N/A	94.75%
Total return CAGR (3Y)	N/A	13.50%
Total return CAGR (5Y)	N/A	-13.52%
Total return CAGR (10Y)	N/A	2.29%

APMD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full APMD analysis Full MLAB analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.